.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,197,316

« Back to Dashboard

Details for Patent: 4,197,316

Title: Treatment of dry skin
Abstract:Preventive as well as therapeutic treatment to alleviate the symptoms of disorders characterized by cracking, flaking or scaling of the skin consisting of the topical application of a lotion, cream or ointment containing one or more of the .alpha.- or .beta.-hydroxy acids or .alpha.-keto acids and esters thereof, their amides and their ammonium salts is disclosed. The compounds include free acid, amide and/or ammonium salt forms of citric acid, glycolic acid, glucuronic acid, galacturonic acid, glucuronolactone, gluconolactone, .alpha.-hydroxybutyric acid, .alpha.-hydroxyisobutyric acid, lactic acid, malic acid, mandelic acid, mucic acid, pyruvic acid, methyl pyruvate, ethyl pyruvate, .beta.-phenyllactic acid, .beta.-phenylpyruvic acid, saccharic acid, tartaric acid, tartronic acid, and .beta.-hydroxybutyric acid. The therapeutic composition may include one or more of the compounds present in the total amount of from one to twenty percent. Topical application to affected areas has been found to achieve amelioration of the dry skin.
Inventor(s): Yu; Ruey J. (Philadelphia, PA), Van Scott; Eugene J. (Rydal, PA)
Assignee:
Filing Date:Jan 17, 1978
Application Number:05/870,114
Claims:1. A non-irritating therapeutic composition for alleviating the symptoms of dry skin in humans comprising: a therapeutically effective amount of a reaction product prepared by reacting, in aqueous or alcoholic aqueous solution at least one member selected from the group consisting of citric acid, glycolic acid, glucuronic acid, galacturonic acid, glucuronolactone, gluconolactone, .alpha.-hydroxybutyric acid, .alpha.-hydroxyisobutyric acid, mandelic acid, mucic acid, pyruvic acid, methyl pyruvate, ethyl pyruvate, .beta.-phenyllactic acid, .alpha.-phenylpyruvic acid, saccharic acid, tartaric acid, tartronic acid, and .beta.-hydroxybutyric acid and a base selected from a group consisting of ammonium hydroxide, an organic primary, secondary, or tertiary alkylamine, alkanolamine, diamine, dialkylamine, dialkanolamine, alkylalkanolamine, trialkylamine, trialkanol amine, dialky alkanol amine, or alkyl dialkanolamine wherein the alkyl or alkanol substituent has from 1 to 8 carbon atoms in a pharmaceutically acceptable vehicle for topical application selected from the group consisting of lotion, cream, and ointment.

2. The composition of claim 1 wherein the product is present in a concentration of from 1 up to about 20 percent by volume of the total composition.

3. The composition of claim 1 wherein the product is present in a concentration of from 2 up to about 10 percent by volume of the total composition.

4. The composition of claim 1 wherein the product comprises a reaction product of a member selected from the group consisting of citric acid, glycolic acid, glucuronic acid, galacturonic acid, glucuronolactone, gluconolactone, .alpha.-hydroxybutyric acid, .alpha.-hydroxyisobutyric acid, mandelic acid, mucic acid, pyruvic acid, methyl pyruvate, ethyl pyruvate, .beta.-phenyllactic acid, .beta.-phenylpyruvic acid, saccharic acid, tartaric acid, tartronic acid, and .beta.-hydroxybutyric acid and a memeber selected from the group consisting of ammonium hydroxide, methylamine, ethylamine, monoethanolamine, monoisopropanolamine, ethylenediamine, 1,2-diaminopropane, dimethylamine, diethylamine, diethanolamine, diisopropanolamine, N-methylethanolamine, N-ethylethanolamine, triethylamine, triethanolamine, N-methyldiethanolamine, and triisopropylamine.

5. The composition of claim 1 wherein the vehicle is at least one member selected from the group consisting of water, ethanol, and propylene glycol present therein in a concentration of up to 99, 70, and 30 percent, respectively.

6. The composition of claim 1 wherein the pH thereof is from 3.5 to about 7.5.

7. The composition of claim 1 comprising: a reaction product of from about 5 to about 7 parts glycolic acid, and about 3 to about 5 parts ethanolamine in about 10 parts water per 100 parts of said vehicle.

8. The composition of claim 1 comprising: a reaction product of about 5 parts glycolic acid and 3 parts ethanolamine in a vehicle of mineral oil, cottonseed oil, isopropyl palmitate, water, and a surfactant present in a ratio of 15:15:5:60:5 per 100 parts of said vehicle.

9. The composition of claim 1 comprising: a reaction product of 10 parts glycolic acid and 7 parts ethanolamine in 20 parts cetyl alcohol, 5 parts polyoxyethylene (20) sorbitan monooleate, 45 parts water, and 10 parts propylene glycol.

10. The composition of claim 1 comprising: a reaction product of 7 parts glycolic acid and 5 parts ethanolamine in 10 parts water in a vehicle of petrolatum, mineral oil, spermaceti, water, and a surfactant present in a ratio of 10:10:6:68:6 parts per 100 parts of said vehicle.

11. A method of alleviating the symptoms of dry skin in humans comprising: topically applying to involved areas of the body an effective amount of a composition comprising: a therapeutically effective amount of a mixture of members of the group selected from citric acid, glycolic acid, glucuronic acid, galacturonic acid, glucuronolactone, gluconolactone, .alpha.-hydroxybutyric acid, .alpha.-hydroxyisobutyric acid, lactic acid, malic acid, mandelic acid, mucic acid, pyruvic acid, methyl pyruvate, ethyl pyruvate, .beta.-phenyllactic acid, .beta.-phenylpyruvic acid, saccharic acid, tartaric acid, tartronic acid, and .beta.-hydroxybutyric acid in a pharmaceutically acceptable vehicle.

12. The method of claim 11 wherein the mixture is present in a concentration of from 1 up to about 20 percent by volume of the total composition.

13. The method of claim 11 wherein the mixture is present in a concentration of from 2 up to about 10 percent by volume of the total composition.

14. The method of claim 11 wherein the composition comprises about 5 parts .alpha.-hydroxyisobutyric acid in 2 parts sorbitol and 8 parts water admixed with 85 parts of a pharmaceutically acceptable vehicle.

15. The method of claim 11 wherein the composition comprises about 2 parts pyruvic acid, 2 parts glycolic acid, 2 parts citric acid, and 2 parts lactic acid in 12 parts water, admixed with 80 parts of said vehicle.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc